F-1/A: Wearable Devices Files F-1/A for Share Resale, Details Dilution Risks

Wearable Devices Ltd. filed an amended registration statement for the resale of up to 1.67 million ordinary shares by a selling shareholder, highlighting significant potential dilution and ongoing financial challenges.

Summary

• Wearable Devices Ltd. filed an Amendment No. 1 to Form F-1 for the resale of up to 1,670,000 Ordinary Shares by a selling shareholder, Armistice Capital, LLC.
• These shares are issuable upon the exercise of 1,000,000 warrants (September 12 Warrants) with an exercise price of $4.00 per share, and 670,000 warrants (September 15 Warrants) with an exercise price of $6.00 per share.
• The company will not receive proceeds from the sale of these shares by the selling shareholder, but expects to receive approximately $8.02 million in cash if all warrants are exercised.
• Wearable Devices is developing a non-invasive neural input interface, including B2C products like the Mudra Band (shipping since December 2023) and Mudra Link (pre-orders September 2024, shipping Q1 2025), and a B2B Mudra Development Kit (selling since 2018).
• Revenues were $522 thousand in 2024 and $82 thousand in 2023, with comprehensive and net losses of $7.9 million and $7.8 million, respectively.
• For the six months ended June 30, 2025, revenues were $294 thousand, and the net loss was $3.7 million.
• The company recently completed registered direct offerings and private placements in September 2025, raising gross proceeds of approximately $4.0 million and $4.02 million from warrant sales, respectively.
• An At-the-Market (ATM) offering agreement was entered into on September 25, 2025, allowing the sale of up to $7.4 million of Ordinary Shares, with 10,000 shares already issued as of September 30, 2025.
• The company's financial statements for the six months ended June 30, 2025, included an explanatory paragraph regarding substantial doubt about its ability to continue as a going concern.

Sentiment

Score: 3

Explanation: The company faces significant financial challenges, evidenced by consistent losses and a "going concern" warning. While it is actively raising capital and commercializing products, the substantial dilution from these capital raises and the long lead time for B2B licensing agreements indicate a highly speculative and risky investment profile.

Positives

• Potential to receive approximately $8.02 million in cash from the exercise of the September 12 and September 15 Warrants, which will be used for working capital and general corporate purposes.
• Active commercialization of B2C products, Mudra Band (shipping since December 2023) and Mudra Link (shipping since Q1 2025).
• Engagement with over 100 B2B customers, including 30 multinational technology companies, exploring the Mudra Development Kit.
• Established At-the-Market (ATM) offering facility for up to $7.4 million, providing flexibility for future capital raises.
• Successful completion of recent registered direct offerings and concurrent private placements in September 2025, securing capital.

Negatives

• The company will not receive any proceeds from the sale of Ordinary Shares by the selling shareholder in this offering.
• Financial statements for the six months ended June 30, 2025, contained an explanatory paragraph regarding substantial doubt about the company's ability to continue as a going concern.
• Reported significant comprehensive and net losses: $7.9 million in 2024, $7.8 million in 2023, $3.7 million for H1 2025, and $4.2 million for H1 2024.
• Revenues remain low: $522 thousand in 2024, $82 thousand in 2023, $294 thousand for H1 2025, and $394 thousand for H1 2024.
• Despite B2B engagement since 2018, no licensing agreements have been signed with any of the over 100 companies that purchased the Mudra Development Kit, with an estimated 3-5 year period to reach such agreements.

Risks

• Shareholders may experience significant dilution from potential future financings, including sales under an effective shelf registration statement (approximately $11.9 million already sold out of $30 million).
• The exercise of the September 12 and September 15 Warrants (1,670,000 Ordinary Shares) could cause existing shareholders to experience dilution, representing approximately 29.6% of outstanding shares prior to the offering.
• Further significant dilution is highly likely from the August 2025 Warrants (3,322,000 Ordinary Shares at an exercise price of $1.71 per share, subject to shareholder approval), which would increase outstanding shares by approximately 58.8%.
• If all September 12, September 15, and August 2025 Warrants are exercised, outstanding Ordinary Shares would increase by approximately 88.4%, leading to substantial dilution.
• Sales of a large number of Ordinary Shares, or the perception of such sales, could cause the market price of Ordinary Shares to decline and impair the ability to raise future capital.
• The company does not anticipate paying any cash dividends in the foreseeable future, meaning capital appreciation is the sole source of gain.
• The financial statements for the six months ended June 30, 2025, contained an explanatory paragraph regarding substantial doubt about the company's ability to continue as a going concern.
• Risks related to the company's ability to maintain and expand its customer base, device compatibility, and business models.
• Challenges in correctly predicting the market growth for its technology.
• Potential inability to remediate material weaknesses in internal control over financial reporting.
• Risks associated with retaining founders and protecting intellectual property.
• Impact of competition, new technologies, general market, political, and economic conditions, including geopolitical conflicts in Israel and the Middle East.
• Risk of not complying with Nasdaq listing requirements.
• Potential litigation.

Future Outlook

The company's vision is to establish the human hand as a universal input device for touchless interaction with digital devices, aiming to set the standard input interface for the Metaverse. It anticipates that neural-based interfaces will become as ubiquitous for wearable computing and digital devices as touchscreens are for smartphones. The company expects a three-to-five-year period from initial customer engagement to signing B2B licensing agreements for its Mudra technology. Future expansion includes neurotech, brain-computer interface sensors, Industry 4.0, digital health, and sport analytics.

Management Comments

• "Our company's vision is to create a world in which the user's hand becomes a universal input device for touchlessly interacting with technology."
• "We believe that our technology is setting the standard input interface for the Metaverse."
• "We intend to transform interaction and control of digital devices to be as natural and intuitive as real-life experiences."
• "We imagine a future in which humans can share skills, thoughts, emotions, and movements with each other and with computers, using wearable interfaces and devices."
• "We believe that neural-based interfaces will become as ubiquitous to interact with wearable computing and digital devices in the near future as the touchscreen is a universal input method for smartphones."

Industry Context

Wearable Devices Ltd. operates in the rapidly evolving wearable technology and human-computer interaction sectors, focusing on neural input interfaces and gesture control. Its technology is positioned to address the growing demand for intuitive interaction with digital devices, including consumer electronics, smartwatches, AR/VR headsets, and potentially the Metaverse. The company's expansion into neurotech, Industry 4.0, digital health, and sport analytics aligns with broader industry trends towards integrating advanced sensor technology and AI for diverse applications.

Comparison to Industry Standards

• NA

Corporate Governance

Legal Proceedings

• General risk of litigation mentioned as a factor that could impact future performance.

Related Party Transactions

• The selling shareholder, Armistice Capital, LLC, purchased warrants from the company in private placements. The company states no other material relationship with the selling shareholder beyond these transactions and ownership of securities.

Stakeholder Impact

• Shareholders: Face significant potential dilution from the exercise of existing and future warrants, which could depress the market price of Ordinary Shares. No cash dividends are anticipated, making capital appreciation the sole source of return.
• Company: Improved liquidity from the exercise of warrants will support working capital and general corporate purposes, aiding in continued operations and commercialization efforts.
• Employees, Directors, and Consultants: Benefit from existing equity incentive plans (options and RSUs), aligning their interests with company performance.
• Customers: Continued development and commercialization of gesture control technology (Mudra Band, Mudra Link, Mudra Development Kit) aims to provide innovative input solutions.
• Creditors: The "going concern" warning indicates increased risk, but the capital raises provide some short-term financial stability.

Next Steps

• The selling shareholder may sell up to 1,670,000 Ordinary Shares from time to time under this prospectus.
• The company intends to use the approximately $8.02 million in cash from warrant exercises for working capital and general corporate purposes.
• Shareholder approval is required for the issuance of the 3,322,000 August 2025 Warrants.
• A further amendment to the registration statement is necessary for it to become effective.
• Continue efforts to commercialize Mudra Band and Mudra Link products.
• Pursue B2B licensing agreements, with an estimated 3-5 year period for completion.
• Address and remediate material weaknesses in internal control over financial reporting.
• Maintain and expand existing customer base and device compatibility.
• Maintain, protect, and enhance intellectual property.
• Comply with Nasdaq listing requirements.

Key Dates

Recommendation

The filing reveals a company in a precarious financial position, explicitly stating "substantial doubt about our ability to continue as a going concern." While recent capital raises provide some liquidity, they come at the cost of severe dilution, with potential increases in outstanding shares by up to 88.4%. Revenues remain minimal, and the path to profitability, particularly through B2B licensing, is projected to be long (3-5 years) with no agreements signed to date. The high degree of risk, coupled with ongoing losses and the explicit going concern warning, suggests that the company faces fundamental challenges that significantly outweigh any perceived positives from product commercialization or capital infusion, making it a highly speculative and unfavorable investment.

Keywords

Wearable Devices Ltd., WLDS, SEC Filing, F-1/A, Registration Statement, Ordinary Shares, Warrants, Resale Offering, Dilution, Capital Raise, Private Placement, Registered Direct Offering, At-the-Market Offering, Mudra Band, Mudra Link, Gesture Control, Neural Input Interface, Wearable Technology, AR/VR, Metaverse, Going Concern, Financial Reporting, Risk Factors, Israel, Technology Company